Fig. 3From: An ex-ante cost-utility analysis of the deemed consent legislation compared to expressed consent for kidney transplantations in Nova ScotiaCost-effectiveness acceptability curve for a 1% increase in deceased donor kidney transplantation probability. QALY quality-adjusted life-yearBack to article page